Healthcare & Life Sciences
Prevention, treatment and management of illness — and enhancement of physical and mental wellbeing — represent global priorities for national economies and individual participants in the healthcare and life sciences sectors. They are increasingly challenged by operational and regulatory demands, correspondingly higher risks of compliance and pressures for improved value and realignment with fundamentally new business models. FTI Consulting works with healthcare and life sciences companies to find innovative solutions that optimize performance in the short term and prepare for future strategic, operational, financial, regulatory and legal challenges.
How We Help
When assisting healthcare and life sciences clients, FTI Consulting draws on deep expertise in turnaround and restructuring, interim management, performance improvement, economics and policy, regulatory compliance, strategic communications and more. We provide strategic advice for healthy and distressed companies in this sector, including financial, cybersecurity, corporate, brand and medical communications. Our services are client centric and focus on mitigating risks and optimizing opportunities in order to support the company’s license to operate.
Turnaround and Restructuring
FTI Consulting’s dedicated healthcare, biopharmaceutical and other life sciences practices have performed...
FTI Consulting’s dedicated healthcare, biopharmaceutical and other life sciences practices have performed extensive work within these industries on Canadian, U.S. and cross-border assignments, including restructuring strategy formulation and execution, and assessment of and assistance with capital solutions.
Our Canadian-based experts have advised clients in assessing current liquidity as well as potential capital-raising opportunities to fund restructuring alternatives.
Interim Management
Our professionals have interim management experience with restructurings in the health and life sciences sector...
Our professionals have interim management experience with restructurings in the health and life sciences sector and can provide a wide array of advisory services addressing the strategic, financial, operational, reputational, regulatory and capital needs of the industry.
